批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2004/11/17 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2024/12/30 |
SUPPL-42(补充) |
Approval |
Labeling-Container/Carton Labels,Labeling-Package Insert |
STANDARD
|
|
|
| 2020/01/10 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/08/11 |
SUPPL-27(补充) |
Approval |
Labeling-Container/Carton Labels |
STANDARD
|
|
|
| 2016/04/29 |
SUPPL-26(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2015/04/29 |
SUPPL-22(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2014/05/09 |
SUPPL-23(补充) |
Approval |
Manufacturing (CMC) |
STANDARD
|
|
|
| 2012/08/30 |
SUPPL-21(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2011/10/06 |
SUPPL-19(补充) |
Approval |
Labeling-Package Insert |
N/A
|
|
|
| 2010/12/23 |
SUPPL-16(补充) |
Approval |
Labeling-Package Insert |
UNKNOWN
|
|
|
| 2008/10/14 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/09/05 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
| 2006/03/23 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
>>>活性成分:IPRATROPIUM BROMIDE; 剂型/给药途径:AEROSOL, METERED;INHALATION; 规格:0.021MG/INH; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 217953 |
001 |
ANDA |
IPRATROPIUM BROMIDE |
IPRATROPIUM BROMIDE |
AEROSOL, METERED;INHALATION |
0.021MG/INH |
Prescription |
No |
No |
AB |
--
|
ARMSTRONG PHARMS |
| 021527 |
001 |
NDA |
ATROVENT HFA |
IPRATROPIUM BROMIDE |
AEROSOL, METERED;INHALATION |
0.021MG/INH |
Prescription |
Yes |
Yes |
AB |
2004/11/27
|
BOEHRINGER INGELHEIM |